Clinical Trial Update: Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial examining Oshadi D and Oshadi R in combination with docetaxel as second-line therapy for metastatic non-small cell lung cancer; status currently u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Oshadi D
• Oshadi R

Snippet

Sponsor: Oshadi Drug Administration | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN